About 1,567,662 results (5,481 milliseconds)

US5994409A - Methods for treatment of neuro--and nephro ...

https://patents.google.com/patent/US5994409A/en
For example, indications or "markers" of neurotoxicity caused by chemotherapy include, but are not limited to clinical signs and symptoms, nerve conduction ...

WO2015116735A1 - Methods and combinations for killing ...

https://patents.google.com/patent/WO2015116735A1/en
(1) Senescence growth arrest is essentially permanent and cannot be reversed by known physiological stimuli. ... caused by a chemotherapy or radiotherapy. For ...

CN112057626A - Methods and compositions for treating peripheral ...

https://patents.google.com/patent/CN112057626A/en
Chemotherapy-induced peripheral neuropathy (CIPN) typically occurs during the treatment ... constant dynamic balance between nerve contraction and regrowth ...

US5605930A - Compositions and methods for treating and ...

https://patents.google.com/patent/US5605930A/en
Their dose of corticosterioids was held constant throughout their treatment ... A third patient with prostate cancer who suffered from suramin-induced sensory ...

WO2017011738A1 - Antagonists of gpr160 for the treatment of pain ...

https://patents.google.com/patent/WO2017011738A1/en
... temporary liner-layer and a permanent backing ... chemotherapy -induced neuropathy, diabetic neuropathy, autoimmune neuropathy, and traumatic neuropathy.

US12037400B2 - Anti-TrkB agonist antibodies binding to D1 domain ...

https://patents.google.com/patent/US12037400B2/en
... permanent MCAO. FIGS. 16A and 16B represent ... In one example, peripheral neuropathy includes Chemotherapy induced peripheral neuropathy (CIPN).

CA2977918C - Role of n-2-hydroxy-ethyl-piperazine-n'-2-ethane ...

https://patents.google.com/patent/CA2977918C/en
... induced by the HEPES moiety will have a permanent curative effect. ... chemotherapy and radiotherapy induced cognitive impairment, neuropathies and inactivity.

US5852056A - Phenylacetate and derivatives alone or in ...

https://patents.google.com/patent/US5852056A/en
Their dose of corticosterioids was held constant throughout their treatment ... A third patient with prostate cancer who suffered from suramin-induced sensory ...

WO2019012149A1 - Therapeutic modulators of the reverse mode of ...

https://patents.google.com/patent/WO2019012149A1/en
In these cancer cells, ΨΙΜ = around -200 rather than the -140 mV in normal adult cells. ROS cause transient growth arrest to permanent growth arrest, to ...

WO2018166495A1 - Novel anti-trkb antibodies - Google Patents

https://patents.google.com/patent/WO2018166495A1/zh
... permanent MCAO. Figure 16 shows sequences provided in the present ... peripheral neuropathy includes Chemotherapy induced peripheral neuropathy (CIPN) .

US9884065B2 - Inhibiting activity of senescent cells using a ...

https://patents.google.com/patent/US9884065B2/en
(1) Senescence growth arrest is essentially permanent and cannot be reversed by known physiological stimuli. ... Chemo- and Radiation-Induced Cognitive ...

US20200316066A1 - Killing senescent cells and treating ...

https://patents.google.com/patent/US20200316066A1/en
(1) Senescence growth arrest is essentially permanent and cannot be reversed by known physiological stimuli. ... caused by a chemotherapy or radiotherapy. For ...

EP3939570A1 - Naltrexone for treating or preventing autoimmune ...

https://patents.google.com/patent/EP3939570A1/en
The thickened synovial tissue, called pannus, releases enzymes, which erode both cartilage and bone to cause permanent damage. [0056]. Rheumatoid arthritis ...

WO2016097831A1 - Treatment of cancer through electronically ...

https://patents.google.com/patent/WO2016097831A1/en
Indications of clinical efficacy were present at a dose that did not cause peripheral neuropathy and at serum concentrations of DCA sufficient to inhibit ...

TITAN II MISSILE VETERANS HEALTH SURVEY RESPONSES

https://sites.google.com/site/titan2vetshealthandwellness/health-surveys/titan-ii-missile-veterans-health-survey-responses
I have severe neuropathy of right foot which I am undergoing therapy presently. I have had it for years. I have been diagnosed with cancer twice. In 2007 I had ...

WO2017070647A1 - Nicotinamide for use in the treatment and ...

https://patents.google.com/patent/WO2017070647A1/en
Jul 6, 2017 ... Vision loss from glaucoma is permanent ... Certain drugs used in cancer chemotherapy such as Taxol, Velcade and vincristine, cause peripheral ...

AU2018205629A1 - Protein therapeutics for treatment of senescent ...

https://patents.google.com/patent/AU2018205629A1/en
... permanent and cannot be reversed by known physiological stimuli; (2) ... caused by a chemotherapy or radiotherapy. For example, toxic side effects ...

WO2015030567A1 - Improvements to a complementary formulation ...

https://patents.google.com/patent/WO2015030567A1/en
Mar 5, 2015 ... ... caused by cancer treatment. Add to its applications, the beneficial ... permanent anxiety tending to post-chemotherapy depression. 2 ...

US20200129549A1 - Use of Plasma and Plasma Fractions for ...

https://patents.google.com/patent/US20200129549A1/en
Chemotherapy-induced peripheral neuropathy occurs in 40-60% of patients both ... Two wounding sites were marked on their dorsal skin with 5 mm-diameter circles ...